Research Appraisalobservational

Fetal cardiac remodeling in second trimester in pregnancies with pre-eclampsia and/or fetal growth restriction: deep-learning-based approach using population-wide data

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and GynecologyTaksøe-Vester, C A, Mikolaj, K, Petersen, O B et al.1 Apr 2026DOI

Clinical Snapshot

100CEBM
Evidence: Strongobservational

PICO Framework

P — Population139,430 singleton pregnancies at 18-22 weeks gestation from Danish national screening program
I — InterventionPre-eclampsia and/or fetal growth restriction exposure
C — ComparatorAppropriate-for-gestational-age fetuses from normotensive pregnancies (reference group)
O — OutcomesFetal cardiac biometric measurements and morphological changes assessed by AI-automated segmentation

Bottom Line

This large Danish cohort study demonstrates that fetal cardiac remodeling occurs as early as the second trimester in pregnancies complicated by pre-eclampsia and/or fetal growth restriction. Pre-eclampsia is associated with enlarged right heart structures and wider pulmonary arteries, while FGR shows smaller cardiac dimensions and altered ventricular geometry. These findings suggest distinct pathophysiological pathways and may have implications for long-term cardiovascular risk stratification. The use of AI-automated measurements on population-wide screening data provides robust evidence for early cardiac programming. Clinicians should be aware that cardiac changes precede traditional third-trimester manifestations, potentially informing earlier risk assessment and intervention strategies. However, the clinical significance of these morphological changes for postnatal outcomes requires further longitudinal study.

Evidence: Strong

Key Findings

  • P Value: Statistically significant differences reported between groups

  • Effect Size: PE associated with enlarged right heart structures and wider main pulmonary artery; FGR associated with smaller cardiac structures and increased left ventricular sphericity

  • Primary Outcome: Distinct patterns of fetal cardiac remodeling in PE vs FGR pregnancies at 18-22 weeks

  • Nnt Or Sensitivity: Z-scores adjusted for abdominal circumference used to quantify morphological differences

  • Confidence Interval: Not explicitly reported in abstract

Clinical Application

Requires standardized cardiac imaging protocols and potentially AI-assisted measurement tools Relevant to Australian antenatal care; could inform RANZCOG guidelines for high-risk pregnancy monitoring and complement existing screening protocols under Medicare Pregnant women undergoing routine second-trimester ultrasound screening

Abstract

OBJECTIVE: Pre-eclampsia (PE) and fetal growth restriction (FGR) have been shown to impact fetal cardiac remodeling in the third trimester and postnatally, with evidence to suggest that this leads to increased long-term cardiovascular risk. This study aimed to examine fetal cardiac remodeling in pregnancies with PE and/or FGR during the second trimester. METHODS: This was a retrospective nationwide cohort study of ultrasound images from routine screening at 18-22 weeks of gestation in Denmark. We included 139 430 singleton pregnancies that were conceived spontaneously for which at least one relevant standardized cardiac plane (four-chamber view and/or three-vessel view) was available from the second-trimester scan. An artificial intelligence model performed automated segmentation and extraction of fetal cardiac biometric measurements. Data were collected for four groups: the reference group, defined as appropriate-for-gestational-age (AGA) fetuses from a normotensive pregnancy (n = 131 150); AGA fetuses from a PE pregnancy (AGA + PE group; n = 3095); FGR fetuses from a normotensive pregnancy (normotensive + FGR group; n = 4572); and FGR fetuses from a PE pregnancy (PE + FGR group; n = 613). Differences between groups in cardiac biometric measurements were presented as Z-scores adjusted for abdominal circumference at the second-trimester scan. RESULTS: Compared with the reference group, fetuses in the PE + AGA group had significantly larger right-sided heart structures, and the main pulmonary artery (MPA) and ventricular septum were wider. Fetuses in the normotensive + FGR group displayed significantly smaller cardiac structures, including smaller MPA and ascending aorta diameters, and increased left ventricular sphericity compared with the reference group. Fetuses in the PE + FGR group differed significantly from the reference group only in terms of smaller left atrial area, narrower ascending aorta and increased left ventricular sphericity. However, PE + FGR fetuses had significantly wider MPA and ventricular septum and larger right-sided structures compared with normotensive + FGR fetuses, mimicking the features of the PE + AGA group, suggesting a distinct effect of PE on fetal cardiac remodeling. CONCLUSIONS: Cardiac remodeling is evident as early as the second trimester, with distinct patterns of modulation in fetuses from pregnancies affected by PE vs FGR. In particular, PE is associated with an enlarged right heart and greater MPA diameter. Understanding these early differences in fetal cardiac morphology may improve risk prediction models and guide early intervention to improve long-term cardiovascular outcome. © 2025 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

References

  1. 1.Taksøe-Vester, C. A., Mikolaj, K., Petersen, O. B., Ekelund, C. K., Vejlstrup, N. G., Vedel, C., Christensen, A. N., Feragen, A., Nielsen, M., & Tolsgaard, M. G. (2026). Fetal cardiac remodeling in second trimester in pregnancies with pre-eclampsia and/or fetal growth restriction: deep-learning-based approach using population-wide data. Ultrasound in Obstetrics & Gynecology, Article 10.1002/uog.70123. https://doi.org/10.1002/uog.70123
Share:XLinkedIn

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service